EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
    1.3.8.8 | -999 |
- |
heterozygous ACADVL mutation carriers show residual VLCAD activities of 23.7 to 54.2% |
700905 |
| 1.3.8.8 | -999 |
- |
residual VLCAD activity of patients with confirmed VLCAD-deficiency is between 0.3 and 1.1% |
700905 |
| 1.3.8.8 | 0.00034 |
- |
crude extract, strain TH183, genotype fadR251(S), acetate and oleate as carbon source |
394658 |
| 1.3.8.8 | 0.00052 |
- |
crude extract, strain TH18, genotype fadR251(S), acetate as carbon source |
394658 |
| 1.3.8.8 | 0.00064 |
- |
crude extract, strain TH182, genotype fadR250(S) acetate as carbon source |
394658 |
| 1.3.8.8 | 0.00083 |
- |
crude extract, strain TH182, genotype fadR250(S), acetate and oleate as carbon source |
394658 |
| 1.3.8.8 | 0.0011 |
- |
crude extract, strain TH181, genotype fadR+, acetate as carbon source |
394658 |
| 1.3.8.8 | 0.00238 |
- |
MCAD activity, controls |
700905 |
| 1.3.8.8 | 0.0038 |
- |
crude extract, strain TH181, genotype fadR+, acetate and oleate as carbon source |
394658 |
| 1.3.8.8 | 0.0046 |
- |
crude extract, strain RS3010, genotype fadR1, acetate as carbon source |
394658 |
